Listed

Candel Therapeutics, Inc.

CADLNasdaqCIK 1841387HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$26.7m, Q2 FY2026
Net income−$38.9m, Q2 FY2026
Candel Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m5.8Research and development, Q3 FY2023, three months to 2023-09-30$5.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0000950170-24-126767.Report this figure7.3Research and development, Q4 FY2023, three months to 2023-12-31$7.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-13, accession 0000950170-25-038803. Derived: 12-month figure less the 9-month figure.Report this figure4.1Research and development, Q1 FY2024, three months to 2024-03-31$4.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0000950170-25-069833.Report this figure5.0Research and development, Q2 FY2024, three months to 2024-06-30$5.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0000950170-25-108450.Report this figure5.4Research and development, Q3 FY2024, three months to 2024-09-30$5.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure4.8Research and development, Q4 FY2024, three months to 2024-12-31$4.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001193125-26-103134. Derived: 12-month figure less the 9-month figure.Report this figure4.0Research and development, Q1 FY2025, three months to 2025-03-31$4.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure7.0Research and development, Q2 FY2025, three months to 2025-06-30$7.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure8.5Research and development, Q3 FY2025, three months to 2025-09-30$8.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure11.0Research and development, Q4 FY2025, three months to 2025-12-31$11.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001193125-26-103134. Derived: 12-month figure less the 9-month figure.Report this figure9.8Research and development, Q1 FY2026, three months to 2026-03-31$9.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure19.8Research and development, Q2 FY2026, three months to 2026-06-30$19.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure
Operating income$m(8.9)Operating income, Q3 FY2023, three months to 2023-09-30−$8.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-126767.Report this figure(10.3)Operating income, Q4 FY2023, three months to 2023-12-31−$10.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-13, accession 0000950170-25-038803. Derived: 12-month figure less the 9-month figure.Report this figure(7.9)Operating income, Q1 FY2024, three months to 2024-03-31−$7.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0000950170-25-069833.Report this figure(8.6)Operating income, Q2 FY2024, three months to 2024-06-30−$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-108450.Report this figure(8.8)Operating income, Q3 FY2024, three months to 2024-09-30−$8.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure(8.1)Operating income, Q4 FY2024, three months to 2024-12-31−$8.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-103134. Derived: 12-month figure less the 9-month figure.Report this figure(8.1)Operating income, Q1 FY2025, three months to 2025-03-31−$8.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure(11.2)Operating income, Q2 FY2025, three months to 2025-06-30−$11.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure(13.2)Operating income, Q3 FY2025, three months to 2025-09-30−$13.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure(15.8)Operating income, Q4 FY2025, three months to 2025-12-31−$15.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-103134. Derived: 12-month figure less the 9-month figure.Report this figure(16.3)Operating income, Q1 FY2026, three months to 2026-03-31−$16.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure(26.7)Operating income, Q2 FY2026, three months to 2026-06-30−$26.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure
Interest expense$m0.7Interest expense, Q3 FY2023, three months to 2023-09-30$669.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-14, accession 0000950170-24-126767.Report this figure(4.5)Interest expense, Q4 FY2023, three months to 2023-12-31−$4.5m. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-13, accession 0000950170-25-038803. Derived: 12-month figure less the 9-month figure.Report this figure0.6Interest expense, Q1 FY2024, three months to 2024-03-31$646.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-13, accession 0000950170-25-069833.Report this figure0.6Interest expense, Q2 FY2024, three months to 2024-06-30$567.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-14, accession 0000950170-25-108450.Report this figure0.5Interest expense, Q3 FY2024, three months to 2024-09-30$487.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure0.4Interest expense, Q4 FY2024, three months to 2024-12-31$390.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-12, accession 0001193125-26-103134. Derived: 12-month figure less the 9-month figure.Report this figure0.3Interest expense, Q1 FY2025, three months to 2025-03-31$306.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure0.2Interest expense, Q2 FY2025, three months to 2025-06-30$236.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure0.2Interest expense, Q3 FY2025, three months to 2025-09-30$161.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure1.4Interest expense, Q4 FY2025, three months to 2025-12-31$1.4m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-12, accession 0001193125-26-103134. Derived: 12-month figure less the 9-month figure.Report this figure1.6Interest expense, Q1 FY2026, three months to 2026-03-31$1.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure1.6Interest expense, Q2 FY2026, three months to 2026-06-30$1.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2023-11-09, accession 0000950170-23-061566. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-13, accession 0000950170-25-038803. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(8.4)Net income, Q3 FY2023, three months to 2023-09-30−$8.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-126767.Report this figure(11.1)Net income, Q4 FY2023, three months to 2023-12-31−$11.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-13, accession 0000950170-25-038803. Derived: 12-month figure less the 9-month figure.Report this figure(8.2)Net income, Q1 FY2024, three months to 2024-03-31−$8.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-13, accession 0000950170-25-069833.Report this figure(22.2)Net income, Q2 FY2024, three months to 2024-06-30−$22.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-108450.Report this figure(10.6)Net income, Q3 FY2024, three months to 2024-09-30−$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure(14.1)Net income, Q4 FY2024, three months to 2024-12-31−$14.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-103134. Derived: 12-month figure less the 9-month figure.Report this figure7.4Net income, Q1 FY2025, three months to 2025-03-31$7.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure(4.8)Net income, Q2 FY2025, three months to 2025-06-30−$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure(11.3)Net income, Q3 FY2025, three months to 2025-09-30−$11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure(29.5)Net income, Q4 FY2025, three months to 2025-12-31−$29.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-103134. Derived: 12-month figure less the 9-month figure.Report this figure(8.9)Net income, Q1 FY2026, three months to 2026-03-31−$8.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure(38.9)Net income, Q2 FY2026, three months to 2026-06-30−$38.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure
Diluted EPS$ per share(0.29)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0000950170-24-126767.Report this figurenot reported(0.28)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0000950170-25-069833.Report this figure(0.74)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0000950170-25-108450.Report this figure(0.33)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figurenot reported0.13Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure(0.09)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure(0.21)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figurenot reported(0.14)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure(0.52)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure
Basic EPS$ per share(0.29)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0000950170-24-126767.Report this figurenot reported(0.28)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0000950170-25-069833.Report this figure(0.74)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.74 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0000950170-25-108450.Report this figure(0.33)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figurenot reported0.15Basic EPS, Q1 FY2025, three months to 2025-03-31$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure(0.09)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure(0.21)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figurenot reported(0.14)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure(0.52)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure

Balance sheet

Cash and equivalents$201.6m, Q2 FY2026
Long-term debt$1.7m, FY2024
Shareholders' equity$126.1m, Q2 FY2026
Candel Therapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m43.0Cash and equivalents, Q3 FY2023, at 2023-09-30$43.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0000950170-23-061566.Report this figure35.4Cash and equivalents, FY2023, at 2023-12-31$35.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-13, accession 0000950170-25-038803.Report this figure25.7Cash and equivalents, Q1 FY2024, at 2024-03-31$25.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0000950170-24-059118.Report this figure21.5Cash and equivalents, Q2 FY2024, at 2024-06-30$21.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0000950170-24-095784.Report this figure16.6Cash and equivalents, Q3 FY2024, at 2024-09-30$16.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0000950170-24-126767.Report this figure103Cash and equivalents, FY2024, at 2024-12-31$102.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-12, accession 0001193125-26-103134.Report this figure92.2Cash and equivalents, Q1 FY2025, at 2025-03-31$92.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0000950170-25-069833.Report this figure101Cash and equivalents, Q2 FY2025, at 2025-06-30$100.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0000950170-25-108450.Report this figure87.0Cash and equivalents, Q3 FY2025, at 2025-09-30$87.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure120Cash and equivalents, FY2025, at 2025-12-31$119.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure195Cash and equivalents, Q1 FY2026, at 2026-03-31$194.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure202Cash and equivalents, Q2 FY2026, at 2026-06-30$201.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure
Current assets$m45.1Current assets, Q3 FY2023, at 2023-09-30$45.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-061566.Report this figure36.8Current assets, FY2023, at 2023-12-31$36.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-13, accession 0000950170-25-038803.Report this figure27.1Current assets, Q1 FY2024, at 2024-03-31$27.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059118.Report this figure22.7Current assets, Q2 FY2024, at 2024-06-30$22.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-095784.Report this figure18.1Current assets, Q3 FY2024, at 2024-09-30$18.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-126767.Report this figure104Current assets, FY2024, at 2024-12-31$103.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-12, accession 0001193125-26-103134.Report this figure93.1Current assets, Q1 FY2025, at 2025-03-31$93.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-069833.Report this figure104Current assets, Q2 FY2025, at 2025-06-30$103.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108450.Report this figure90.1Current assets, Q3 FY2025, at 2025-09-30$90.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure121Current assets, FY2025, at 2025-12-31$121.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure198Current assets, Q1 FY2026, at 2026-03-31$197.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure204Current assets, Q2 FY2026, at 2026-06-30$204.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure
Total assets$m50.1Total assets, Q3 FY2023, at 2023-09-30$50.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-061566.Report this figure41.2Total assets, FY2023, at 2023-12-31$41.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-13, accession 0000950170-25-038803.Report this figure31.2Total assets, Q1 FY2024, at 2024-03-31$31.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0000950170-24-059118.Report this figure26.5Total assets, Q2 FY2024, at 2024-06-30$26.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0000950170-24-095784.Report this figure21.5Total assets, Q3 FY2024, at 2024-09-30$21.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0000950170-24-126767.Report this figure107Total assets, FY2024, at 2024-12-31$106.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-12, accession 0001193125-26-103134.Report this figure95.9Total assets, Q1 FY2025, at 2025-03-31$95.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0000950170-25-069833.Report this figure106Total assets, Q2 FY2025, at 2025-06-30$106.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0000950170-25-108450.Report this figure93.6Total assets, Q3 FY2025, at 2025-09-30$93.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure125Total assets, FY2025, at 2025-12-31$125.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure202Total assets, Q1 FY2026, at 2026-03-31$201.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure208Total assets, Q2 FY2026, at 2026-06-30$208.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure
Current liabilities$m10.3Current liabilities, Q3 FY2023, at 2023-09-30$10.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-061566.Report this figure14.2Current liabilities, FY2023, at 2023-12-31$14.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-13, accession 0000950170-25-038803.Report this figure13.5Current liabilities, Q1 FY2024, at 2024-03-31$13.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059118.Report this figure14.0Current liabilities, Q2 FY2024, at 2024-06-30$14.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-095784.Report this figure15.3Current liabilities, Q3 FY2024, at 2024-09-30$15.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-126767.Report this figure37.5Current liabilities, FY2024, at 2024-12-31$37.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-12, accession 0001193125-26-103134.Report this figure20.1Current liabilities, Q1 FY2025, at 2025-03-31$20.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-069833.Report this figure14.7Current liabilities, Q2 FY2025, at 2025-06-30$14.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108450.Report this figure10.9Current liabilities, Q3 FY2025, at 2025-09-30$10.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure9.0Current liabilities, FY2025, at 2025-12-31$9.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure7.1Current liabilities, Q1 FY2026, at 2026-03-31$7.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure12.7Current liabilities, Q2 FY2026, at 2026-06-30$12.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure
Total liabilities$m27.0Total liabilities, Q3 FY2023, at 2023-09-30$27.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-061566.Report this figure28.5Total liabilities, FY2023, at 2023-12-31$28.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-13, accession 0000950170-25-038803.Report this figure25.2Total liabilities, Q1 FY2024, at 2024-03-31$25.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0000950170-24-059118.Report this figure36.5Total liabilities, Q2 FY2024, at 2024-06-30$36.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0000950170-24-095784.Report this figure36.8Total liabilities, Q3 FY2024, at 2024-09-30$36.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0000950170-24-126767.Report this figure40.5Total liabilities, FY2024, at 2024-12-31$40.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-12, accession 0001193125-26-103134.Report this figure21.2Total liabilities, Q1 FY2025, at 2025-03-31$21.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0000950170-25-069833.Report this figure15.8Total liabilities, Q2 FY2025, at 2025-06-30$15.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0000950170-25-108450.Report this figure13.5Total liabilities, Q3 FY2025, at 2025-09-30$13.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure73.3Total liabilities, FY2025, at 2025-12-31$73.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure63.9Total liabilities, Q1 FY2026, at 2026-03-31$63.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure82.0Total liabilities, Q2 FY2026, at 2026-06-30$82.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure
Long-term debt$m14.3Long-term debt, Q3 FY2023, at 2023-09-30$14.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-09, accession 0000950170-23-061566.Report this figure11.6Long-term debt, FY2023, at 2023-12-31$11.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2024-03-28, accession 0000950170-24-037637.Report this figure9.2Long-term debt, Q1 FY2024, at 2024-03-31$9.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059118.Report this figure6.7Long-term debt, Q2 FY2024, at 2024-06-30$6.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-13, accession 0000950170-24-095784.Report this figure4.2Long-term debt, Q3 FY2024, at 2024-09-30$4.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-14, accession 0000950170-24-126767.Report this figure1.7Long-term debt, FY2024, at 2024-12-31$1.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-13, accession 0000950170-25-038803.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$m6.1Current portion of debt, Q3 FY2023, at 2023-09-30$6.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-061566.Report this figure8.9Current portion of debt, FY2023, at 2023-12-31$8.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-03-13, accession 0000950170-25-038803.Report this figure9.8Current portion of debt, Q1 FY2024, at 2024-03-31$9.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059118.Report this figure9.8Current portion of debt, Q2 FY2024, at 2024-06-30$9.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-095784.Report this figure9.9Current portion of debt, Q3 FY2024, at 2024-09-30$9.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-126767.Report this figure9.9Current portion of debt, FY2024, at 2024-12-31$9.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-12, accession 0001193125-26-103134.Report this figure9.2Current portion of debt, Q1 FY2025, at 2025-03-31$9.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-069833.Report this figure6.7Current portion of debt, Q2 FY2025, at 2025-06-30$6.7m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108450.Report this figure4.2Current portion of debt, Q3 FY2025, at 2025-09-30$4.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure0.0Current portion of debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-12, accession 0001193125-26-103134.Report this figurenot reportednot reported
Shareholders' equity$m23.0Shareholders' equity, Q3 FY2023, at 2023-09-30$23.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0000950170-24-126767.Report this figure12.7Shareholders' equity, FY2023, at 2023-12-31$12.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-12, accession 0001193125-26-103134.Report this figure6.0Shareholders' equity, Q1 FY2024, at 2024-03-31$6.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0000950170-25-108450.Report this figure(10.0)Shareholders' equity, Q2 FY2024, at 2024-06-30−$10.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure(15.3)Shareholders' equity, Q3 FY2024, at 2024-09-30−$15.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure66.3Shareholders' equity, FY2024, at 2024-12-31$66.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure74.7Shareholders' equity, Q1 FY2025, at 2025-03-31$74.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure90.2Shareholders' equity, Q2 FY2025, at 2025-06-30$90.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure80.1Shareholders' equity, Q3 FY2025, at 2025-09-30$80.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure51.9Shareholders' equity, FY2025, at 2025-12-31$51.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure138Shareholders' equity, Q1 FY2026, at 2026-03-31$138.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure126Shareholders' equity, Q2 FY2026, at 2026-06-30$126.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure

Cash flow

Operating cash flow−$17.2m, Q2 FY2026
Capital expenditure$69.0k, Q2 FY2026
Candel Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(8.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$8.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0000950170-24-126767. Derived: 9-month figure less the 6-month figure.Report this figure(7.4)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$7.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-13, accession 0000950170-25-038803. Derived: 12-month figure less the 9-month figure.Report this figure(8.4)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$8.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0000950170-25-069833.Report this figure(6.2)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$6.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0000950170-25-108450. Derived: 6-month figure less the 3-month figure.Report this figure(6.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$6.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-279086. Derived: 9-month figure less the 6-month figure.Report this figure(5.8)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$5.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001193125-26-103134. Derived: 12-month figure less the 9-month figure.Report this figure(8.6)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$8.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure(8.9)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$8.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-347980. Derived: 6-month figure less the 3-month figure.Report this figure(10.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$10.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-279086. Derived: 9-month figure less the 6-month figure.Report this figure(10.6)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$10.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001193125-26-103134. Derived: 12-month figure less the 9-month figure.Report this figure(18.0)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$18.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure(17.2)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$17.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-347980. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q3 FY2023, three months to 2023-09-30$103.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0000950170-24-126767. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$47.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-13, accession 0000950170-25-038803. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0000950170-25-069833.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0000950170-25-108450. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-279086. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001193125-26-103134. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$31.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-347980. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$144.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-279086. Derived: 9-month figure less the 6-month figure.Report this figure0.4Capital expenditure, Q4 FY2025, three months to 2025-12-31$409.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001193125-26-103134. Derived: 12-month figure less the 9-month figure.Report this figure0.7Capital expenditure, Q1 FY2026, three months to 2026-03-31$675.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$69.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-347980. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)74.13m, Q2 FY2026
Candel Therapeutics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares28.9Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3028,891,909 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-061566.Report this figure28.9Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3128,919,810 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0000950170-24-059118.Report this figure28.9Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3028,919,810 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0000950170-24-095784.Report this figure28.9Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3028,919,810 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0000950170-24-126767.Report this figure29.2Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3129,197,537 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0000950170-25-069833.Report this figure29.9Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3029,878,210 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0000950170-25-108450.Report this figure32.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3032,013,569 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure54.8Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3154,765,842 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure51.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3051,489,929 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure54.9Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3054,894,347 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-279086.Report this figure62.4Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3162,361,897 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-222904.Report this figure74.1Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3074,131,229 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure

Shares outstanding: 76.52mShares outstanding, period not labelled, at 2026-08-0676,518,565 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-347980.Report this figure at Aug 6, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.